PlainRecalls
FDA Drug Moderate Class II Ongoing

Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01

Reported: December 24, 2025 Initiated: November 17, 2025 #D-0239-2026

Product Description

Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01

Reason for Recall

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Details

Units Affected
575 1x10 Foil Blister Packs
Distribution
Natinowide in the USA
Location
Anaheim, CA

Frequently Asked Questions

What product was recalled?
Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01. Recalled by Preferred Pharmaceuticals, Inc.. Units affected: 575 1x10 Foil Blister Packs.
Why was this product recalled?
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 24, 2025. Severity: Moderate. Recall number: D-0239-2026.